Cigna Group

Cigna Group (CI) faces an antitrust investigation in Canada for its Express Scripts unit's alleged anti-competitive practices, potentially impacting profitability and reputation [1]. This comes as the FTC's lawsuit against Express Scripts for similar practices in the US resumes, increasing legal and financial risks [6]. Despite these challenges, Cigna's RS Rating improved, reflecting positive stock performance [8], and the company boasts strong long-term revenue growth and substantial scale [5]. However, customer growth lags behind competitors [5]. Cigna also engaged in positive PR through a community support initiative with Magic Johnson [2], and will release Q1 2025 financial results on May 2nd [7].